ApprovalTrail

Approval · Notice of Compliance 3580 · 2003

RAPAMUNE: Notice of Compliance 3580

Issued March 10, 2003

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
3580
Date
March 10, 2003
Company
Wyeth CanadaSt. Laurent, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Immunosuppressive agent

Products in this notice

BrandDINStatus today
RAPAMUNE02243237Marketed
RAPAMUNE02247111Marketed

Medicinal ingredients